Children With Sickle Cell Disease Need A Good Night's Sleep
Children with sickle cell disease tend to have interrupted sleep many times during the night leaving them tired and irritable during the day.
Diagnostics
Pages: 1 [2]
News From The Journal Of Clinical Investigation, July 20, 2009
commentary, Geneviève de Saint Basile and Gaël Ménasché, at INSERM U768, France, highlight the importance of this work and suggest future studies to define more precisely the molecular stage of lytic granule formation controlled by EBAG9. TITLE: The tumor-associated antigen EBAG9 negatively regulates the cytolytic capacity of mouse CD8+ T cells https://www.the-jci.org/article.php?id=37760 AUTHOR CONTACT: Armin Rehm Max-DelbrÃøck-Center for Molecular Medicine, Berlin, Germany. Uta E. Höpken Max-DelbrÃøck-Center for Molecular Medicine, Berlin, Germany. ACCOMPANYING COMMENTARY TITLE: EBAG9 tempers lymphocyte killing activity https://www.the-jci.org/article.php?id=40270 AUTHOR CONTACT: Geneviève de Saint Basile INSERM U768, Paris, France. HEPATOLOGY: Balancing liver regeneration and injury In some clinical situations, surgical removal of a massive proportion of the liver or transplantation with a partial liver graft (something known as small-for-size transplantation) is the only option. In both contexts, liver regeneration is crucial to the success of the procedure. One factor linked to impaired liver regeneration is the extent of ischemia-reperfusion injury (IRI), an unavoidable consequence of surgery that occurs when blood reenters the tissues after a period of oxygen deprivation (ischemia). Previous studies have implicated the complement system, a group of blood proteins activated sequentially in inflammatory situations, in both IRI and liver regeneration. In a new study, Stephen Tomlinson and colleagues, at the Medical University of South Carolina, Charleston, have revealed the existence of a balance between complement-dependent injury and regeneration in a combined mouse model of IRI and removal of large portions of the liver. In particular, there was a threshold of complement activation above which it promoted liver regeneration, and this involved the proteins ASP and C5L2. The authors therefore suggest that therapeutic modulation of the complement system might help prevent liver regeneration failure in patients who have had large proportions of their liver removed or undergone small-for-size transplantation. TITLE: A complement-dependent balance between hepatic ischemia/reperfusion injury and liver regeneration in mice https://www.the-jci.org/article.php?id=38289 AUTHOR CONTACT: Stephen Tomlinson Medical University of South Carolina, Charleston, South Carolina, USA. Karen Honey Journal of Clinical InvestigationPages: 1 [2]